ISHLT 2024-4040-Shah

ISHLT 2024-1304-Pintens

ISHLT 2024-789-Lampert

ISHLT 2024-408-Kim

ATC 2024-D65-Williams

ATC 2024-D50-Bole

ATC 2024-C70-Bole

Stage III CRC Case Study

Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer

DENEB: Development of a new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stage I to III Colorectal Cancer

A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca

Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy effi

Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer

Post-operative ctDNA monitoring in stage I colon cancer: A case report

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Powles T, Assaf ZA, Davarpanah N, et al. Nature.

Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder

Szabados B, Kockx M, Assaf ZA, et al. European Urology.

Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival.

Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case